Clinical experiences with 6-monthly paliperidone palmitate beyond the diagnosis of schizophrenia. A retrospective study

被引：0
|
作者：
Lopez, S. Benavente [1 ]
Mendoza, S. Bolano [1 ]
Gonzalez, A. Parra [1 ]
Fernandez, A. Lara [1 ]
Nevado, A. Herencias [1 ]
Garcia, E. Baca [1 ]
机构：
[1] Hosp Univ Infanta Elena, Psychiat, Madrid, Spain
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0758
引用
收藏
页码：S489 / S489
页数：1
相关论文
共 50 条
  • [21] Early schizophrenia patients treated with once-monthly paliperidone palmitate over a 12-month period - A Retrospective Observational Study
    Schreiner, Andreas
    Bergmans, Paul
    Cherubin, Pierre
    Hargarter, Ludger
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 223 - 224
  • [22] Clinical effectiveness of early treatment with paliperidone palmitate in schizophrenia: A retrospective real-world study in South Korea
    Shin, Wonsuk
    Lee, Dong Hyeon
    Kim, Min-Kyoung
    Lee, Sang-Hyuk
    Cho, Doo-Yeoun
    Bang, Minji
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (06) : 1759 - 1767
  • [23] The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study
    Oh, So-Young
    Jon, Duk-In
    Hong, Hyun Ju
    Hong, Narei
    Yi, Jung-Seo
    Roh, Daeyoung
    Jung, Myung Hun
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2019, 17 (04) : 531 - 536
  • [24] Once-monthly paliperidone palmitate in early stage schizophrenia - a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia
    Emsley, Robin
    Hargarter, Ludger
    Bergmans, Paul
    Uglesic, Boran
    Sengul, Abdullah Cem
    Petralia, Antonino
    Khannanova, Angelina
    Cherubin, Pierre
    Schreiner, Andreas
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2261 - 2269
  • [25] Patient reported outcomes from schizophrenia patients treated with paliperidone palmitate 1-monthly for at least 6 months (picture study)
    Vega, M.
    Arques, S.
    Herrera, B.
    Garcia-Dorado, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S944 - S945
  • [26] Aripiprazole once-monthly is superior to paliperidone palmitate: results from QUALIFY, a randomized, head-to-head clinical study in schizophrenia
    Potkin, S. G.
    Loze, J.
    Forray, C.
    Baker, R. A.
    Sapin, C.
    Peters-Strickland, T.
    Beillat, M.
    Nylander, A.
    Hertel, P.
    Andersen, H. S.
    Eramo, A.
    Hansen, K.
    Naber, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S529 - S530
  • [27] Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study
    Garcia-Carmona, Juan Antonio
    Garcia-Perez, Alba
    Isidro Garcia, Guillermo
    Forcen-Munoz, Luis Alberto
    Ovejero Garcia, Santiago
    Saez Povedano, Rocio
    Gonzalez-Galdamez, Ana Luisa
    Mata Iturralde, Laura
    Hernandez-Sanchez, Fernando
    Ramirez Bonilla, Mariluz
    Fuentes-Perez, Paloma
    Ovejas-Catalan, Claudia
    Suarez-Pinilla, Paula
    Valdivia-Munoz, Francisco
    Fernandez Abascal, Blanca
    Omana Colmenares, Miguel
    de Lourdes Martin-Perez, Angela
    Campos-Navarro, Maria Pilar
    Baca-Garcia, Enrique
    Benavente-Lopez, Sergio
    Raya Platero, Alberto
    Barberan Navalon, Miguel
    Sanchez-Alonso, Sergio
    Vazquez-Bourgon, Javier
    Pappa, Sofia
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2023, 13
  • [28] Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
    Li, Xin
    Ye, Chong
    Zhang, Wanyi
    Jia, Miaomiao
    Wang, Gang
    CNS DRUGS, 2024, 38 (01) : 55 - 65
  • [29] Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
    Xin Li
    Chong Ye
    Wanyi Zhang
    Miaomiao Jia
    Gang Wang
    CNS Drugs, 2024, 38 : 55 - 65
  • [30] Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia
    Naber, Dieter
    Hansen, Karina
    Forray, Carlos
    Baker, Ross A.
    Sapin, Christophe
    Beillat, Maud
    Peters-Strickland, Timothy
    Nylander, Anna-Greta
    Hertel, Peter
    Andersen, Henrik Steen
    Eramo, Anna
    Loze, Jean-Yves
    Potkin, Steven G.
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 498 - 504
12345